- Service Name
SanBio Regenerative Medicine
- Industry
Healthcare, Biotechnology, Regenerative Medicine, Cell Therapy
- Main Value Proposition
SanBio aims to deliver groundbreaking regenerative medicine solutions that improve the health and quality of life for patients with central nervous system disorders.
- Description
SanBio is a regenerative medicine company focused on developing, manufacturing, and selling cell therapies for central nervous system diseases such as stroke and traumatic brain injury. Their flagship product, SB623, aims to provide innovative treatments for patients suffering from these conditions.
- Key Features
Development of SB623 for chronic stroke and traumatic brain injury; Mass production technology for cell therapies; Top-level research and development team; Focus on making treatments accessible to a larger patient population
- Use Cases
SanBio's therapies are most valuable for patients suffering from chronic stroke and traumatic brain injuries, where traditional treatments may be insufficient.
- Competitive advantages
Expertise in regenerative medicine and iPS cell research; Successful mass production of living cells over a decade; Focus on chronic conditions with significant unmet medical needs
- Strengths
SanBio's strengths lie in its innovative R&D capabilities, a world-class development team, and a strong commitment to patient accessibility in regenerative medicine.
- Positioning
SanBio positions itself as a leader in regenerative medicine, focusing on innovative cell therapies that address critical health challenges.
- Audience
The target users include patients with central nervous system disorders, healthcare professionals, and researchers in regenerative medicine.
- CTA
Contact Us
- Tags
Regenerative Medicine
Cell Therapy
SB623
Chronic Conditions
- Tagline
Pioneering Regenerative Medicine
- Tone of Voice
Innovative, compassionate, professional
- Differentiation
SanBio differentiates itself through its commitment to allogeneic cell therapies, which allow for mass production and cost reduction compared to autologous therapies, making treatments more accessible.
- Brand Positioning
SanBio's brand identity is centered around pioneering advancements in regenerative medicine, emphasizing innovation, accessibility, and patient care.
- Founded
2013-02-27
- Founders
Keita Mori
Mori Keita
Toru Kawanishi
Yoshihiro Kakutani